Aardvark Therapeutics Quote - AARD | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Aardvark Therapeutics Inc (AARD) Share Price

Aardvark Therapeutics Inc (AARD)

14.01

0.27

( 1.97% )

Updated: 04:30:36

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

14.01

Bid

13.89

Offer

14.13

Volume

47,784

13.96 Day's Range 15.5999

12.58 52 Week Range 19.58

Previous Close

13.74

Open

14.22

Last Trade

Last Trade Time

04:30:36

Average Volume (3m)

241,636

Financial Volume

US$ 707,655

VWAP

14.8095

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Aardvark Therapeutics Announces Pricing of Initial Public Offering

SAN DIEGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (“Aardvark”) (Nasdaq: AARD), a clinical-stage biopharmaceutical company...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.32	2.33747260774	13.69	19.58	12.58	258356	15.41188588	CS
4	-0.09	-0.63829787234	14.1	19.58	12.58	241636	15.10641599	CS
12	-0.09	-0.63829787234	14.1	19.58	12.58	241636	15.10641599	CS
26	-0.09	-0.63829787234	14.1	19.58	12.58	241636	15.10641599	CS
52	-0.09	-0.63829787234	14.1	19.58	12.58	241636	15.10641599	CS
156	-0.09	-0.63829787234	14.1	19.58	12.58	241636	15.10641599	CS
260	-0.09	-0.63829787234	14.1	19.58	12.58	241636	15.10641599	CS

AARD - Frequently Asked Questions (FAQ)

What is the current Aardvark Therapeutics share price?

The current share price of Aardvark Therapeutics is US$ 14.01

What is the 1 year trading range for Aardvark Therapeutics share price?

Aardvark Therapeutics has traded in the range of US$ 12.58 to US$ 19.58 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
STECSantech Holdings Limited	US$ 1.7732 (172.67%)	102.4M
PEPGPepGen Inc	US$ 2.83 (106.57%)	97.91M
YYAIConnexa Sports Technologies Inc	US$ 1.185 (85.13%)	115.12M
RETOReTo Eco Solutions Inc	US$ 0.738 (81.82%)	65.23M
ATPCAgape ATP Corporation	US$ 1.3999 (49.56%)	67.37M
THTarget Hospitality Corporation	US$ 4.35 (-53.53%)	7.93M
NKLANikola Corporation	US$ 0.2549 (-32.92%)	35.67M
WDCWestern Digital Corporation	US$ 49.37 (-28.14%)	6.9M
WIMIWiMi Hologram Cloud Inc	US$ 0.921 (-27.48%)	16.68M
STAIScanTech AI Systems Inc	US$ 2.4397 (-25.84%)	3.26M
NVDANVIDIA Corporation	US$ 134.40 (-0.02%)	141.63M
PLTRPalantir Technologies Inc	US$ 92.5216 (-8.71%)	121.81M
YYAIConnexa Sports Technologies Inc	US$ 1.185 (85.13%)	115.12M
CNEYCN Energy Group Inc	US$ 0.2561 (4.70%)	109.59M
STECSantech Holdings Limited	US$ 1.76 (170.64%)	102.4M

peanutz

peanutz 4 minutes ago

This is thin to .2 cents on level 2

Lime Time

Lime Time 4 minutes ago

32m bidding. No fills

tedpeele

tedpeele 4 minutes ago

PDSB $21 target just out, stock reversing: DJ PDS Biotechnology Price Target Maintained With a $21.00/Share by HC Wainwright

chemist72

chemist72 4 minutes ago

Don't forget the commissions ($6.95 on Schwab - lol)

glenn1919

glenn1919 4 minutes ago

ISPC.......CHEK,,,,,,,SPGC.......FOXO......................https://stockcharts.com/h-sc/ui?s=CHEK&p=D&yr=0&mn=3&dy=0&id=p11960084343

linkvest

linkvest 5 minutes ago

RS is not on the table and only being talked about with losers that probably sold out and now want back in. Filings should be out shortly and with MILLIONS in REVs showing these TRIP shares will be a thing of the past.

Hoskuld

Hoskuld 5 minutes ago

If you mean, "at what point in the review process are negative outcomes determined?", then I think the answer is "at the very end". Companies do withdraw their applications of course - probably at CS2 - but denials seem to come out after both clock stops have passed.

I agree that n

Krombacher

Krombacher 5 minutes ago

JohnnyDollar,

You’ve hit on a critical point. Otterman once pushed for revocation, claiming it was the “economical” choice. But let’s break that down:

1️⃣ Revocation wipes out all shareholders—so if Otterman was truly a shareholder, why would he advocate for total destr

Jefedejefes

Jefedejefes 5 minutes ago

Were is pumper pimp Crawfors as the stock slides deeper.

gp22

gp22 5 minutes ago

IMMUNO NEWS: $ESLA @ $1.30s: Volume precedes price...Volume & price. Up over last few sessions. Given $16 target last week by big bio/pharma ETF.. Revolutionary immuno bio/pharma play. Made huge gains on $IOVA & holding $APVO too.
$ESLA Powering up. News link:
9/29/24
https://f

236T568

236T568 5 minutes ago

Meanwhile, the protests outside the same Republican congressman's town hall meeting

https://x.com/ArtCandee/status/1894077017747750967

gp22

gp22 5 minutes ago

IMMUNO NEWS: $ESLA @ $1.30s: Volume precedes price...Volume & price. Up over last few sessions. Given $16 target last week by big bio/pharma ETF.. Revolutionary immuno bio/pharma play. Made huge gains on $IOVA & holding $APVO too.
$ESLA Powering up. News link:
9/29/24
https://f

DL11

DL11 5 minutes ago

Seems to be holding the 200 day MA ($53.07) and well above the 50 day MA ($35.65),..with that 50 day MA increasing rapidly, soon to overtake the 200 day MA. As for CVNA, well, yes, it's down today, but look at the 1 year chart. Very much on an upward trend, moving between the 50 day and 200 day MA.

manibiotech

manibiotech 6 minutes ago

I don't believe what's said on phone anymore .
Why don't you get it in an email and then tell us .

vlispxpert

vlispxpert 6 minutes ago

LITM .42 gtc filled...nice!!

Shawonsarker84

Shawonsarker84 6 minutes ago

Good afternoon everyone! HMBL has been reset at RSI level 25 on Friday at close. Let's go

DavidLeeRoth

DavidLeeRoth 6 minutes ago

Bashers aren’t getting my shares.😎 ASII LONG💰

https://investorshub.advfn.com/uimage/uploads/2024/11/15/deimvIMG_0402.jpeg

PEACHMAN

PEACHMAN 6 minutes ago

All the paid bashers of IFUS except 2 clowns have been pretty quiet

Uber last posted on Dec 18th when he guaranteed IFUS would be sub penny

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175548990

Pantherj/kitty/pinocchio has not posted h

gp22

gp22 6 minutes ago

IMMUNO NEWS: $ESLA @ $1.30s: Volume precedes price...Volume & price. Up over last few sessions. Given $16 target last week by big bio/pharma ETF.. Revolutionary immuno bio/pharma play. Made huge gains on $IOVA & holding $APVO too.
$ESLA Powering up. News link:
9/29/24
https://f

TrendTrade2016

TrendTrade2016 6 minutes ago

STTK BUILDING MOMO

BeerIsGood

BeerIsGood 6 minutes ago

Will need to be a bit higher
. . . Mexedia S.p.A., a leading telecommunications and technology company listed on Euronext Growth in Paris, has completed the acquisition of its U.S. and Irish operational units by the U.S.-based Raadr Inc. (listed on OTC Markets). The transaction was complet

jog49

jog49 7 minutes ago

"So many variables and permutations that the commons could be near worthless to north of $200/share (no srs or warrants/no cap raise)."

So, you're the driver of the MANURE WAGON. Worst case scenario, commons will still own 20.1% of the corporations. And you think that is "near worthle

Aardvark Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions